Villalonga Juan Francisco, Alessandro Lucas, Farez Mauricio Franco, Mormandi Rubén, Cervio Andrés, Alcorta Santiago Condomí, Muggeri Alejandro
Departmento de Neurocirurgía, Fundación para la Lucha contas las Enfermedades Neurologicas de la Infancia, Buenos Aires, Argentina.
Center for Research on Neuroimmunological Diseases, Buenos Aires, Argentina.
Arq Neuropsiquiatr. 2018 Mar;76(3):139-144. doi: 10.1590/0004-282x20180002.
Background Primary central nervous system lymphomas (PCNSL) are infrequent. The traditional treatment of choice is chemotherapy. Complete resections have generally not been recommended, because of the risk of permanent central nervous system deficits with no proven improvement in survival. The aim of the current study was to compare survival among patients with PCNSL who underwent biopsy versus surgical resection. Methods A retrospective study was conducted on 50 patients with a confirmed diagnosis of PCNSL treated at our center from January 1994 to July 2015. Results Patients in the resection group exhibited significantly longer median survival time, relative to the biopsy group, surviving a median 31 months versus 14.5 months; p = 0.016. Conclusions In our series, patients who had surgical resection of their tumor survived a median 16.5 months longer than patients who underwent biopsy alone.
原发性中枢神经系统淋巴瘤(PCNSL)并不常见。传统的治疗选择是化疗。一般不建议进行完全切除,因为存在永久性中枢神经系统缺陷的风险,且未证实对生存率有改善。本研究的目的是比较接受活检与手术切除的PCNSL患者的生存率。方法:对1994年1月至2015年7月在我们中心接受确诊的50例PCNSL患者进行回顾性研究。结果:与活检组相比,切除组患者的中位生存时间显著更长,中位生存期分别为31个月和14.5个月;p = 0.016。结论:在我们的系列研究中,接受肿瘤手术切除的患者比仅接受活检的患者中位生存期长16.5个月。